Tyra Biosciences, Inc.
TYRA
$25.32
$0.301.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.91% | -16.17% | -13.28% | -6.30% | 0.17% |
| Total Depreciation and Amortization | 0.00% | 4.55% | 0.76% | -6.43% | -2.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.19% | 4.28% | 4.79% | 26.20% | 2.09% |
| Change in Net Operating Assets | 452.12% | -147.57% | 1,194.97% | 114.28% | 53.69% |
| Cash from Operations | 4.59% | -37.87% | -5.56% | 5.49% | 6.98% |
| Capital Expenditure | 25.00% | -54.39% | -46.15% | -25.81% | -121.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.91% | -448.95% | 333.18% | -170.67% | -34.78% |
| Cash from Investing | 114.85% | -449.78% | 332.18% | -170.96% | -34.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.71% | 3,369.63% | 623.80% | 10.98% | -73.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -98.69% | 3,324.79% | 623.80% | 10.98% | -73.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -246.93% | -50.97% | 142.25% | -1,537.79% | -125.48% |